Research Interests
I am currently funded to study the immune response to influenza, HIV-1, and syphilis. As part of this, my laboratory is investigating the antibody response to these pathogens and quantifying the diversity of Fc-receptors that interact with these antibodies to mediate immune activity.
Selected Grants
Stimulating Access to Research in Residency (StARR) - NIAID
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2029A Global Syphilis Vaccine Targeting Outer Membrane Proteins of Treponema pallidum
ResearchPrincipal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2024 - 2029Structure-function analysis of infection- and vaccine-induced B-cell repertoires
ResearchPrincipal Investigator · Awarded by Boston Children's Hospital · 2023 - 2028CIVICs C (75N93019C00054) Option 14
ResearchInvestigator · Awarded by National Institutes of Health · 2022 - 2026CIVICs A - Option 23K
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2026CIVICs A - Option 22C
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2026Heterosubtypic immunity to influenza virus mediated by MHC-E-restricted memory NK cells
ResearchCollaborator · Awarded by National Institute of Allergy and Infectious Diseases · 2021 - 2026Research Training in Allergy and Clinical Immunology
Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2000 - 2026CIVICs A - Option 23H
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2026A biorepository of specimens for syphilis diagnostics (Bio4S) collected from well-characterized syphilis patients
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2022 - 2026Duke Center for Advancement of Child Health (CAtCH).
Inst. Training Prgm or CMEMentor · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2021 - 2026Infectious Diseases in Africa (IDA) Training Symposium for Next Gen Scientists
ConferenceCollaborator · Awarded by National Institutes of Health · 2024 - 2026CIVICS A Opt 7
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2025 - 2026CIVICS Component C - Option 5
ResearchInvestigator · Awarded by National Institutes of Health · 2019 - 2025CIVICS A Opt 23I Soluble multivalent hemagglutinin immunogens to improve seasonal vaccines
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2025CIVICs A Opt 22B Development of a model to assess maternal antibody interference in NHPs
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2025CIVICs A Option 22A Preclinical testing of 20 HA mRNA-LNP vaccine
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2025CIVICs A Opt 23J - Modality testing for InvVax invariant influenza vaccine and possible synergy between T cell and antibody vaccines
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2025CIVICS Component A - Option 5
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2025CIVICS A Opt 28A
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2025CIVICS A Opt 12E
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2025CIVICs A Option 12C Viral Stock and Critical Reagent Propagation for CIVICs Program Use
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2025Interdisciplinary Research Training Program in AIDS
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2025CIVICs A - DCVC Proposed Option 10C
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2025CIVICs A - DCVC Proposed Option 9D
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2025Immunogenicity and risk of autoimmune cross-reactivity of COVID-19 mRNA vaccines in SLE - RRF Investigator Award
ResearchMentor · Awarded by Rheumatology Research Foundation · 2022 - 2025Emerging Infectious Diseases - Coordination Center
ResearchPrincipal Investigator · Awarded by Research Triangle Institute International · 2020 - 2025Immunological Correlates of Syphilis Protection
ResearchPrincipal Investigator · Awarded by University of Connecticut · 2019 - 2025CIVICs A - Option 23G
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2024EQAPOL - Years 2017 to 2024 - BASE
ResearchDirector · Awarded by National Institutes of Health · 2017 - 2024COVID-19 Adaptive VAriant Immunologic Landscape Trial or COVAIL Trial
Clinical TrialInvestigator · Awarded by Leidos Biomedical Research, Inc. · 2022 - 2024Transplant Infectious Diseases Interdisciplinary Research Training Grant (TIDIRTG)
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024CIVICs A - DCVC Proposed Option 9C
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2024CIVICs A - DCVC Proposed Option 10B
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2024CIVICs A - Option 18D
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2024CIVICs A - Option 23E
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2024CIVICs A - Option 23D
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2024Genomic epidemiology of Treponema pallidum strains infecting women and men in low-income countries to inform syphilis vaccine development (INV-036560)
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2021 - 2024CIVICs A - Option 23F
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2024CIVICs A - Option 12B
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2024Vaccine and Treatment Evaluation Units (VTEU)
ResearchInvestigator · Awarded by National Institutes of Health · 2013 - 2023CIVICs A - Option 9B
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2023CIVICs A - Option 10A
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2023CORonavirus VAriant Sequencing (CORVASEQ) Surveillance Network
ResearchInvestigator · Awarded by University of North Carolina - Chapel Hill · 2021 - 2023Immunomodulatory Biomaterials via Peptide and Protein Self-Assembly
ResearchCollaborator · Awarded by National Institutes of Health · 2009 - 2023CIVICs A - Option 12A
ResearchPrincipal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2021 - 2023CIVICs A - Option 23A
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2022CIVICs A - Option 9A
ResearchPrincipal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2021 - 2022Early life B cell responses and inflammation following SARS-CoV-2 infection
ResearchCollaborator · Awarded by National Institutes of Health · 2021 - 2022Combined Hepatitis B and HIV-1 Envelope Infant Vaccination to Augment T cell Help through Enhanced Linked Recognition
ResearchMentor · Awarded by National Institutes of Health · 2017 - 2022VTEU Task Area A - FY.2020.A1B1C1D1.0123 - Option 1
ResearchSenior Investigator · Awarded by National Institutes of Health · 2020 - 2021Role of neutralizing antibodies in HIV-1-infected and vaccinated mothers in MTCT
ResearchCollaborator · Awarded by National Institutes of Health · 2016 - 2021HVTN Phase 1 Protocol Funding
Clinical TrialPrincipal Investigator · Awarded by Fred Hutchinson Cancer Research Center · 2018 - 2020International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT) Group
ResearchCo-Principal Investigator · Awarded by University of California - Los Angeles · 2016 - 2020VTEU Task Area A - FY.2020.A1B1C1D1.0123 - Base
ResearchSenior Investigator · Awarded by National Institutes of Health · 2019 - 2020VTEU RTOP FY.2019.A1B1C1D1.0103 - Task A - Base
ResearchSenior Investigator · Awarded by National Institutes of Health · 2018 - 2019CISA - 2017 TO# 07 - TDAP IIV in Pregnant Women (LEAD) Logical Follow-On - Option 3
ResearchInvestigator · Awarded by Centers for Disease Control and Prevention · 2017 - 2018CISA - 2017 TO# 07 - TDAP IIV in Pregnant Women (LEAD) Logical Follow-On - Option 1
ResearchInvestigator · Awarded by Centers for Disease Control and Prevention · 2017 - 2018CISA - 2017 TO# 07 - TDAP IIV in Pregnant Women (LEAD) Logical Follow-On - Option 2
ResearchInvestigator · Awarded by Centers for Disease Control and Prevention · 2017 - 2018CISA: 2015 CISA 03 - Lead Site Optional Task 1 (Combined Options 1-11): Additional Subjects for Maternal Tdap and IIV Study (Lead)
Clinical TrialCo Investigator · Awarded by Centers for Disease Control and Prevention · 2016 - 2018VTEU FY.2018.A1B1C1D1.0077 Task Area A - Base
ResearchSenior Investigator · Awarded by National Institutes of Health · 2017 - 2018VTEU Task B Option 2 - FY.2017.A1B1C1D1.0048
ResearchSenior Investigator · Awarded by National Institutes of Health · 2017 - 2018CARE Duke-UNC Latency Biomarker Supplement Year 2
ResearchCo Investigator · Awarded by University of North Carolina - Chapel Hill · 2016 - 2018Broad neutralizing antibodies against HIV-1 from RV217 participants
ResearchPrincipal Investigator · Awarded by Henry M. Jackson Foundation · 2014 - 2018VTEU Task Area B Option 2 Protocol FY.2016.B1.0026
ResearchSenior Investigator · Awarded by National Institutes of Health · 2016 - 2017EQAPOL Option 47
ResearchMedical Director · Awarded by National Institutes of Health · 2011 - 2017EQAPOL - Option 48 - 2016 to 2017 - LUMINEX
ResearchMedical Director · Awarded by National Institutes of Health · 2010 - 2017EQAPOL - 2016 to 2017 - Option 6 - BASE
ResearchMedical Director · Awarded by National Institutes of Health · 2010 - 2017EQAPOL Option 5
ResearchMedical Director · Awarded by National Institutes of Health · 2010 - 2017B-cell repertoire analysis in influenza vaccination and infection
ResearchCo Investigator · Awarded by Boston Children's Hospital · 2015 - 2017VTEU Task A Option 1 - FY.2017.A1B1C1D1.0048
ResearchSenior Investigator · Awarded by National Institutes of Health · 2017 - 2017VTEU Task A Base - FY.2017.A1B1C1D1.0048
ResearchSenior Investigator · Awarded by National Institutes of Health · 2016 - 2017Focus 1: Detection of HIV Antigen-Positive Cells
ResearchCo Investigator · Awarded by University of North Carolina - Chapel Hill · 2016 - 2017VTEU Task Area B Option 2 Protocol FY.2016.B1.0026
ResearchSenior Investigator · Awarded by National Institutes of Health · 2016 - 2017Structure-function Analysis of Infection and Vaccine Induced B-Cell Reoertiures-Supplement
ResearchPrincipal Investigator · Awarded by Boston Children's Hospital · 2015 - 2016VTEU Task Area A, Base Protocol FY.2016.A1.0026
ResearchSenior Investigator · Awarded by National Institutes of Health · 2015 - 2016VTEU Task Area A - FY.2015.A1.0016 Base
ResearchSenior Investigator · Awarded by National Institutes of Health · 2014 - 2015VTEU 12-0016: Task Area C: Protocol implementation
Clinical TrialInvestigator · Awarded by National Institutes of Health · 2014 - 2015Subcontract from UAB for Tetramer Production
ResearchPrincipal Investigator · Awarded by University of Alabama at Birmingham · 2014 - 2014Mucosal antibody protection against postnatal SIV transmission in natural hosts of SIV
ResearchCo Investigator · Awarded by National Institutes of Health · 2012 - 2014External Relationships
- Grid Therapeutics, LLC
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.